Key facts
- This page summarizes Douglas E. Coltharp's Form 4 filing for Encompass Health Corp (EHC).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2023, 11:15.
Douglas E. Coltharp - 23 Feb 2023 Form 4 Insider Report for Encompass Health Corp (EHC)
- Reporting relationship
- EVP & Chief Financial Officer
- Issuer ticker
- EHC
- Reported as of
- 23 Feb 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 24 Feb 2023, 11:15:00 UTC
- Prior SEC filing
- 22 Feb 2023
- Next SEC filing
- 28 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Patrick Darby, attorney-in-fact for Mr. Coltharp
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Douglas E. Coltharp filed Form 4 for Encompass Health Corp (EHC) on 24 Feb 2023.
Change
- Previous filing in this sequence was filed on 22 Feb 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EHC
transaction
Encompass Health Common Stock
Award
- Transaction value
- $0
- Shares
- +22,902
- Change %
- +44%
- Price
- $0.000000
- Shares after
- 75,217
- Date
- 23 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
EHC
transaction
Encompass Health Common Stock
Award
- Transaction value
- $0
- Shares
- +37,586
- Change %
- +50%
- Price
- $0.000000
- Shares after
- 112,803
- Date
- 23 Feb 2023
- Ownership
- Direct
- Footnotes
- F2
EHC
holding
Encompass Health Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 125,631
- Date
- 23 Feb 2023
- Ownership
- By irrevocable trust for the benefit of children
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
This issuance of restricted stock is the result of the satisfaction of certain performance criteria set out in the terms of a performance share unit award made on February 24, 2021.
Footnote F2
Award of restricted stock pursuant to the Corporation's 2016 Omnibus Performance Incentive Plan.